Probiotic Color Cosmetic Compositions And Methods

• US 20110223219A1
• Filed: 03/12/2010
• Published: 09/15/2011
• Est. Priority Date: 03/12/2010
• Status: Active Grant

• Current Assignee: ELC Management LLC (The Estee Lauder Companies Inc.)
• Original Assignee: ELC Management LLC (The Estee Lauder Companies Inc.)
• Inventors: Mercado, Clara G., Dao, Khanh Ngoc, Logalbo, John F.
• Granted Patent: US 8,465,731 B2
• Time in Patent Office: Days
• US Class Current: 424/401
• CPC Class Codes: A61K 2800/75 Anti-irritant
• CPC Class Codes: A61K 8/26 Aluminium; Compounds thereof
• CPC Class Codes: A61K 8/9728 Fungi, e.g. yeasts
• CPC Class Codes: A61K 8/9789 Magnoliopsida [dicotyledons]
• CPC Class Codes: A61K 8/99 from microorganisms other than algae or fungi, e.g. protozoa or bacteria
• CPC Class Codes: A61P 17/00 Drugs for dermatological disorders
• CPC Class Codes: A61Q 1/02 Preparations containing skin colorants, e.g. pigments preparations in powder form A61Q1/12
• CPC Class Codes: A61Q 1/12 Face or body powders for grooming, adorning or absorbing

Abstract

A probiotic color cosmetic composition comprising at least one extract from a probiotic microorganism; at least one non-clay lamellar phyllosilicate mineral particulate; and at least one anti-inflammatory ingredient present in an amount sufficient to inhibit one or more of the pathways that contribute to skin inflammation; and a method for treating skin for improvement by applying to skin in need of such improvement the composition of the invention.

Claims

1. A probiotic color cosmetic composition comprising at least one extract from a probiotic microorganism;

at least one non-clay lamellar phyllosilicate mineral particulate; and

at least one anti-inflammatory ingredient present in an amount sufficient to inhibit one or more of the pathways that contribute to skin inflammation.

2. The composition of claim 1 wherein the non-clay lamellar phyllosilicate mineral particulate has a pH value ranging from about 5 to 11.

3. The composition of claim 1 where the probiotic microorganism is a bacteria.

4. The composition of claim 1 wherein the probiotic microorganism is a bacteria from the genus Lactobacillus.

5. The composition of claim 1 wherein the phyllosilicate mineral particulate is from the mica group.

6. The composition of claim 5 wherein the phyllosilicate mineral particulate comprises mica.

7. The composition of claim 1 wherein the probiotic microorganism extract comprises Lactobacillus ferment;

the non-clay lamellar phyllosilicate mineral particulate comprises mica having a pH value ranging from 5 to 9; and

the at least one anti-inflammatory ingredient is a botanical extract.

8. The composition of claim 7 wherein the anti-inflammatory botanical extract is an inhibitor of one or more of the following pathways:

Adhesion, Chemotaxis, Collagenase, COX, Elastase, Histamine, Histamine Receptor, LO, PDE, PLA-2, or VEGF.

9. The composition of claim 8 wherein the anti-inflammatory botanical extract is an inhibitor of one or more of the Adhesion pathway, Chemotaxis pathway, Elastase Pathway, or Histamine Pathway.

10. The composition of claim 1 wherein the probiotic microorganism extract is from Lactobacillus.

11. The composition of claim 10 wherein the lamellar mineral particulate is mica.

12. The composition of claim 11 wherein the anti-inflammatory ingredient is selected from the Citrus group.

13. The composition of claim 12 which is a pigmented emulsion and comprises at least one emulsifying siloxane elastomer, at least one silicone resin, at least one linear silicone surfactant.

14. The composition of claim 12 which is a pigmented anhydrous powder where the Lactobacillus probiotic microorganism extract is spray dried onto the particulates present in the composition prior to their incorporation into the composition.

15. The composition of claim 10 further comprising at least one clay phyllosilicate mineral particulate and at least one non-clay phyllosilicate mineral particulate.

16. The composition of claim 15 wherein the clay phyllosilicate material is bentonite and the non-clay phyllosilicate mineral is mica;

where the probiotic microorganism extract is from Lactobacillus, and the anti-inflammatory ingredient is from the Citrus genus.

17. A method for treating skin for improvement comprising applying to skin in need of improvement a color cosmetic composition comprising at least one probiotic microorganism extract;

at least one lamellar mineral particulate; and

at least one naturally occurring anti-inflammatory ingredient present in the composition in an amount sufficient to inhibit one or more of the pathways that contribute to skin inflammation.

18. The method of claim 17 wherein the composition is a foundation makeup, blush, eyeshadow, concealer, or lipstick.

19. The method of claim 18 wherein the composition is applied once per day.

20. The method of claim 17 wherein the improvement to be treated is irritation, inflammation, or normalization of skin.